Table 1

Angiographic follow-up (3–42 months) for each patient, with anatomical type and flow diverter stent type

Patient NoA1 typeFD type36812131418243042
1H1SilkTOTO
2H3SilkNRTO
3H1SurpassTOARAR
4H3 – H1SilkTOARCoilingTO
5H3SilkNRNR
6H1FRED JRAR
7H1SilkTOTOTO
8H3FRED JRARNRNR
9H1SilkTOTO
10H2FRED JRTO
11H1PEDTOTO
12H2FRED JRARAR
13H2PED
14H1SILKTO
15H1Silk
16H2SilkTO
17H1SurpassTO
18H1FRED JR
19H1PED
20H1SilkNRNRTO
21H2PEDTO
22H3PEDTOTOTO
23H2SilkARNRNRNR
24H2SilkTOTO
25H2Silk
26H1SilkTO
27H1PEDTOTOTO
28H1Silk
29H1PEDTOTOTO
30H1PED
  • AR, aneurysm remnant; FD, flow diverter; FRED, flow redirection endoluminal device; NR, neck remnant; PED, pipeline embolization device; TO, total occlusion; WEB, Woven EndoBridge device.